ScholarIQanswers from OpenAlex & ORCID
Xiaojiao Li
ResearcherPublications, citations & collaboration network
Xiaojiao Li is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Xiaojiao Li have?
ScholarIQindexed works
Xiaojiao Li has 44 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Xiaojiao Li have?
ScholarIQcitation count
Xiaojiao Li has 481 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Xiaojiao Li?
ScholarIQh-index
Xiaojiao Li has an h-index of 13 in OpenAlex.
What is the i10-index of Xiaojiao Li?
ScholarIQi10-index
Xiaojiao Li has an i10-index of 16 in OpenAlex.
What is the ORCID of Xiaojiao Li?
ScholarIQorcid
The ORCID for Xiaojiao Li is on the source record.
What is the OpenAlex record for Xiaojiao Li?
ScholarIQopenalex
The OpenAlex for Xiaojiao Li is on the source record.
What are the most-cited papers on Xiaojiao Li?
ScholarIQmost cited works
K<sup>+</sup> Efflux Antiporters 4, 5, and 6 Mediate pH and K<sup>+</sup> Homeostasis in Endomembrane Compartments
Xiaojie Zhu, Ting Pan, Xiao Zhang, Ligang Fan, Francisco J. Quintero, Hong Zhao, Xiaomeng Su, Xiaojiao Li, Irène Villalta, Imelda Mendoza, Jinbo Shen, Liwen Jiang, José M. Pardo, Quan‐Sheng Qiu
PH13 improves soybean shade traits and enhances yield for high-density planting at high latitudes
Chao Qin, Yinghui Li, Delin Li, Xueru Zhang, Lingping Kong, Yonggang Zhou, Xiangguang Lyu, Ronghuan Ji, Xiu‐Zhi Wei, Qican Cheng, Zhiwei Jia, Xiaojiao Li, Qiang Wang, Yueqiang Wang, Wen Huang, Chunyan Yang, Like Liu, Xing Wang, Guangnan Xing, Guoyu Hu, Zhihui Shan, Ruizhen Wang, Haiyan Li, Hongyu Li, Tao Zhao, Jun Liu, Yuping Lu, Xiping Hu, Fanjiang Kong, Lijuan Qiu, Bin Liu
Global incidence and death estimates of chronic kidney disease due to hypertension from 1990 to 2019, an ecological analysis of the global burden of diseases 2019 study
Yan Liu, Qin He, Qiying Li, Min Tian, Xiaojiao Li, Xufeng Yao, Dongmei He, Chunying Deng
Safety, pharmacokinetics and efficacy of donafenib in treating advanced hepatocellular carcinoma: report from a phase 1b trial
Jingrui Liu, Xiaojiao Li, Hong Zhang, Guiling Chen, Hong Chen, Yue Hu, Junqi Niu, Yanhua Ding
A Phase I, Randomized, Single-Dose Study to Evaluate the Biosimilarity of QL1206 to Denosumab Among Chinese Healthy Subjects
Hong Zhang, Min Wu, Xiaoxue Zhu, Cuiyun Li, Xiaojiao Li, Jixuan Sun, Chengjiao Liu, Quan Liu, Wei Wei, Junqi Niu, Yanhua Ding